**Core Concept**
The MC (most common) gene involved in endometrial carcinoma is a tumor suppressor gene. It plays a crucial role in regulating cell growth and preventing uncontrolled cell division, which is a hallmark of cancer. Mutations in this gene can lead to the development of endometrial cancer.

**Why the Correct Answer is Right**
The correct answer is **PTEN**. PTEN (phosphatase and tensin homolog deleted on chromosome 10) is a tumor suppressor gene that is frequently mutated in endometrial carcinoma. It regulates the PI3K/AKT signaling pathway, which promotes cell survival and proliferation. When PTEN is mutated, it can lead to uncontrolled cell growth and the development of cancer. PTEN mutations are found in approximately 40% of endometrial carcinomas, making it the most common genetic mutation associated with this disease.

**Why Each Wrong Option is Incorrect**
* **Option A:** **TP53** is a tumor suppressor gene involved in many types of cancer, but it is not the most common gene mutated in endometrial carcinoma.
* **Option B:** **BRCA1** and **BRCA2** are tumor suppressor genes involved in breast and ovarian cancer, but they are not commonly mutated in endometrial carcinoma.
* **Option C:** **HER2** is an oncogene involved in breast cancer, but it is not commonly mutated in endometrial carcinoma.

**Clinical Pearl / High-Yield Fact**
PTEN mutations are more common in endometrioid endometrial carcinomas, which are the most common subtype of endometrial cancer. Identifying PTEN mutations can help guide treatment decisions and improve outcomes for patients with endometrial carcinoma.

**Correct Answer: C. PTEN**